November 25, 2024
TRISCEND: 6-Month Outcomes of Transfemoral TVR in Patients With Tricuspid Regurgitation

TRISCEND: 6-Month Outcomes of Transfemoral TVR in Patients With Tricuspid Regurgitation

Video by PCR via YouTube
Go to Source
TRISCEND: 6-Month Outcomes of Transfemoral TVR in Patients With Tricuspid Regurgitation

TCT 2021: Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at #TCT2021. Tbey discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.

— View the full TCT 2021 coverage here:
https://www.pcronline.com/News/Whats-new-on-PCRonline/2021/TCT-2021/PCRonline-at-TCT-2021
— Find out more about the PCR Tricuspid Focus Group here:
https://www.pcronline.com/Network/Tricuspid-Focus-Group

#PCRtricuspid #TreatTR #FixTR

Go to Source